Fusion Pharmaceuticals Inc
FUSN·Stocks·Biotechnology·Canada·Nasdaq·USD
Price
$21.01
Today
+0.1%
YTD
-2.4%
About
Founded in 2014, Fusion Pharmaceuticals Inc. is a clinical-stage oncology company working to develop radiopharmaceuticals as precision medicine. Operating within Canada, the company is headquartered in Hamilton, Ontario. Stock for Fusion Pharmaceuticals uses the FUSN ticker on the NASDAQ GS. Learn more about FUSN stock by adding the company to your eToro watchlist.
Price chart
Closing price history for FUSN (1D candles).
Open positions
Current open positions for this instrument from your live portfolio.
Open positions
0
Unrealized return
+0.0%
No open positions exist for this instrument at the moment.
Financial insights
Valuation
P/E (TTM)-15.21
P/S (TTM)884.98
P/B (TTM)7.56
Market cap$1.83B
Cap tierSmall-cap
Industry avg P/E-6.09
Profitability
Gross margin-32.21%
EBIT margin-5403.77%
Net margin-860.02%
ROE-47.11%
ROA-35.33%
Earnings & Revenue
Revenue (TTM)$2.04M
Revenue growth (1Y)+125.7%
EPS (TTM)-$1.42
Free cash flow$-86.90M
Total debt$64.55M
Dividends & Risk
Dividend rate$0.00
Dividend yield0.00%
Beta (5Y)0.45
Employees113
Trade history
Closed trades
0
Realized return
+0.0%
No stored closed trades exist for this instrument yet.